BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38842175)

  • 1. Cholesterol Metabolism in Neurodegenerative Diseases.
    He K; Zhao Z; Zhang J; Li D; Wang S; Liu Q
    Antioxid Redox Signal; 2024 Jun; ():. PubMed ID: 38842175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.
    Dai L; Zou L; Meng L; Qiang G; Yan M; Zhang Z
    Mol Neurobiol; 2021 May; 58(5):2183-2201. PubMed ID: 33411241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases.
    Vance JE
    Dis Model Mech; 2012 Nov; 5(6):746-55. PubMed ID: 23065638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
    Petrov AM; Kasimov MR; Zefirov AL
    Acta Naturae; 2016; 8(1):58-73. PubMed ID: 27099785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain cholesterol homeostasis and its association with neurodegenerative diseases.
    Gao Y; Ye S; Tang Y; Tong W; Sun S
    Neurochem Int; 2023 Dec; 171():105635. PubMed ID: 37949118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders.
    Yasamineh S; Mehrabani FJ; Derafsh E; Danihiel Cosimi R; Forood AMK; Soltani S; Hadi M; Gholizadeh O
    Mol Neurobiol; 2024 Jun; 61(6):3503-3527. PubMed ID: 37995080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders.
    Turri M; Marchi C; Adorni MP; Calabresi L; Zimetti F
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 May; 1867(5):159123. PubMed ID: 35151900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Intersection of cerebral cholesterol metabolism and Alzheimer's disease: Mechanisms and therapeutic prospects.
    Liu LC; Liang JY; Liu YH; Liu B; Dong XH; Cai WH; Zhang N
    Heliyon; 2024 May; 10(9):e30523. PubMed ID: 38726205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol metabolism and homeostasis in the brain.
    Zhang J; Liu Q
    Protein Cell; 2015 Apr; 6(4):254-64. PubMed ID: 25682154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?
    Valenza M; Cattaneo E
    Prog Neurobiol; 2006 Nov; 80(4):165-76. PubMed ID: 17067733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LXR Regulation of Brain Cholesterol: From Development to Disease.
    Courtney R; Landreth GE
    Trends Endocrinol Metab; 2016 Jun; 27(6):404-414. PubMed ID: 27113081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol Metabolism in the Brain and Its Association with Parkinson's Disease.
    Jin U; Park SJ; Park SM
    Exp Neurobiol; 2019 Oct; 28(5):554-567. PubMed ID: 31698548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxysterols as biomarkers in neurodegenerative diseases.
    Leoni V; Caccia C
    Chem Phys Lipids; 2011 Sep; 164(6):515-24. PubMed ID: 21515244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol in the Pathogenesis of Alzheimer's, Parkinson's Diseases and Autism: Link to Synaptic Dysfunction.
    Petrov AM; Kasimov MR; Zefirov AL
    Acta Naturae; 2017; 9(1):26-37. PubMed ID: 28461971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).
    Mukherjee S
    Heliyon; 2021 Dec; 7(12):e08518. PubMed ID: 34926857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases.
    Coisne C; Tilloy S; Monflier E; Wils D; Fenart L; Gosselet F
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27999408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-dependent effect of sublethal copper concentrations on de novo cholesterol synthesis in astrocytes and their possible links to variations in cholesterol and amyloid precursor protein levels in neuronal membranes.
    Zubillaga M; Tau J; Rosa D; Bellini MJ; Arnal N
    Biol Sex Differ; 2024 Jan; 15(1):4. PubMed ID: 38191520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic approaches for Parkinson's disease by targeting brain cholesterol homeostasis.
    Pingale TD; Gupta GL
    J Pharm Pharmacol; 2021 Jun; 73(7):862-873. PubMed ID: 33822122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases.
    Bowerman M
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32932920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.